| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Eledon Pharmaceuticals, Inc. (ELDN) has 6 insiders with recent SEC Form 4 filings, including 7 buys and 7 sells. ELDN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 3.4K | $13.3K | - | |
| Dir | 3.4K | $13.3K | - | |
| Dir | 3.4K | $13.3K | - | |
| Dir | 3.4K | $13.3K | - | |
| Dir | 3.4K | $13.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 21, 2019 | Kuwahara Jon | See Remarks | Sell | 5,276 | $1.95 | $10,296.29 | -28.9% | |
| May 21, 2019 | Turkel Catherine C. | President | Sell | 9,537 | $1.95 | $18,611.70 | -5.1% | |
| May 21, 2019 | Flesher Gregory J. | Chief Executive Officer | Sell | 14,638 | $1.95 | $28,566.46 | -4.4% | |
| May 2, 2019 | Orbimed Israel GP Ltd. | Director, 10% Owner | Buy | 646,204 | $3.10 | $2,003,232.40 | +25.5% | |
| May 2, 2019 | Chimovits Erez | Director | Buy | 646,204 | $3.10 | $2,003,232.40 | +25.5% | |
| Apr 30, 2019 | Lifesci Index Partners LLC | 10% Owner | Sell | 200 | $2.70 | $540.00 | - | |
| Sep 12, 2018 | Turkel Catherine C. | President | Buy | 33,680 | $4.78 | $161,146.70 | +31.7% | |
| Sep 5, 2018 | Turkel Catherine C. | President | Buy | 805 | $3.97 | $3,192.63 | New | |
| May 10, 2017 | Turkel Catherine C. | Chief Development Officer | Buy | 11,111 | $9.99 | $110,998.89 | +82.9% | |
| May 10, 2017 | Flesher Gregory J. | Chief Executive Officer | Buy | 58,959 | $9.99 | $589,000.41 | +103.6% |